Related Experiment Video

Updated: May 8, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma

Krishna P L Bhat1, Veerakumar Balasubramaniyan2, Brian Vaillant3

  • 1Department of Pathology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.

Cancer Cell
|September 3, 2013
PubMed

Insights

Glioblastoma subtypes (proneural and mesenchymal) exhibit distinct characteristics. Proneural glioblastoma stem cells can differentiate into mesenchymal subtypes, leading to radioresistance and poorer patient survival.

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Molecular Oncology

Background:

  • Glioblastoma (GBM) remains a challenging brain tumor with limited therapeutic targets.
  • Patient-derived glioma sphere cultures (GSCs) can be classified into transcriptomal subtypes, including proneural (PN) and mesenchymal (MES).

Purpose of the Study:

  • To investigate the biological differences between PN and MES GSCs.
  • To elucidate the mechanisms driving PN to MES differentiation and its impact on radioresistance.
  • To explore the role of the tumor microenvironment in this differentiation process.

Main Methods:

  • Characterization of patient-derived GSCs representing PN and MES subtypes.
  • Analysis of TNF-α/NF-κB signaling pathway in GSC differentiation.
  • Assessment of CD44 expression and radioresistance phenotypes.
  • Investigation of tumor microenvironment components, including macrophages/microglia.

Main Results:

  • PN and MES GSCs display significant differences in biological characteristics.
  • A subset of PN GSCs differentiates into MES GSCs via a TNF-α/NF-κB-dependent pathway.
  • This differentiation is associated with CD44 enrichment and acquired radioresistance.
  • Macrophages/microglia within the tumor microenvironment appear to play a role in this process.
  • MES signature, CD44 expression, and NF-κB activation correlate with poor radiation response and survival in GBM patients.

Conclusions:

  • The differentiation of PN to MES GSCs, influenced by the tumor microenvironment, contributes to glioblastoma radioresistance.
  • Targeting the TNF-α/NF-κB pathway and CD44 may offer therapeutic strategies for glioblastoma.

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...